Pharma-Bio Serv, Inc. (PBSV) Form 8-K — Jun 15, 2026
Pharma-Bio Serv, Inc. reported financial results for the quarter ended April 30, 2026, showing revenue growth for both the three and six-month periods compared to the prior year. Revenues reached approximately $2.7 million for the quarter and $5.0 million for the six months, driven by demand for its compliance and project management services. Net income also improved, reaching approximately $0.2 million for the quarter and $0.3 million for the six months, reflecting disciplined cost management and operational efficiency.
Key figures
- Revenue
- 2.7 million
- Net Income
- 0.2 million
- Revenue six months
- 5.0 million
- Net income six months
- 0.3 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.